XML 47 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
OPERATING SEGMENT AND GEOGRAPHIC INFORMATION (Tables)
 6 Months Ended
Jun. 30, 2012
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
 
 
 
 
 
 
 
 
 
Dollars in Thousands
 
2011
 
Clinical Laboratories
 
Pharmacogenomic Services
 
Diagnostic
Tools
 
Total
Net Sales
$
3,864

 
$
1,002

 
$
2,801

 
$
7,667

Gross Profit
2,429

 
635

 
1,491

 
4,555

Net Loss before Taxes
(5,456
)
 
(287
)
 
(359
)
 
(6,102
)
Income Tax Benefit
—

 
—

 
(104
)
 
(104
)
Net Loss
$
(5,456
)
 
$
(287
)
 
$
(255
)
 
$
(5,998
)
Depreciation/Amortization
$
407

 
$
37

 
$
55

 
$
499

Restructure
$
—

 
$
—

 
$
11

 
$
11

Interest Expense, net
$
(240
)
 
$
—

 
$
—

 
$
(240
)
 
 
 
 
 
 
 
 
 
June 30, 2011
Total Assets
$
20,663

 
$
1,958

 
$
8,079

 
$
30,700

 
 
 
 
 
 
 
 
 
Dollars in Thousands
 
2011
 
Clinical Laboratories
 
Pharmacogenomic Services
 
Diagnostic
Tools
 
Total
Net Sales
$
7,351

 
$
1,272

 
$
6,525

 
$
15,148

Gross Profit
4,328

 
522

 
3,892

 
8,742

Net Income (Loss) before Taxes
(8,745
)
 
(534
)
 
393

 
(8,886
)
Income Tax Benefit
—

 
—

 
(110
)
 
(110
)
Net Income (Loss)
$
(8,745
)
 
$
(534
)
 
$
503

 
$
(8,776
)
Depreciation/Amortization
$
801

 
$
71

 
$
120

 
$
992

Restructure
$
—

 
$
—

 
$
35

 
$
35

Interest Expense, net
$
(473
)
 
$
—

 
$
(5
)
 
$
(478
)
 
 
 
 
 
 
 
 
Segment information for the three months ended June 30, 2012 and 2011 is as follows:
 
 
Dollars in Thousands
 
2012
 
Clinical Laboratories
 
Pharmacogenomic Services
 
Diagnostic
Tools
 
Total
Net Sales
$
5,460

 
$
348

 
$
3,285

 
$
9,093

Gross Profit
3,035

 
82

 
1,445

 
4,562

Net Income (Loss) before Taxes
(446
)
 
(178
)
 
31

 
(593
)
Income Tax Benefit
—

 
—

 
(30
)
 
(30
)
Net Income (Loss)
$
(446
)
 
$
(178
)
 
$
61

 
$
(563
)
Depreciation/Amortization
$
431

 
$
36

 
$
65

 
$
532

Interest Expense, net
$
(215
)
 
$
(6
)
 
$
(10
)
 
$
(231
)
 
 
 
 
 
 
 
 
 
June 30, 2012
Total Assets
$
29,082

 
$
2,019

 
$
13,571

 
$
44,672

Segment information for the six months ended June 30, 2012 and 2011 is as follows:
 
Dollars in Thousands
 
2012
 
Clinical Laboratories
 
Pharmacogenomic Services
 
Diagnostic
Tools
 
Total
Net Sales
$
8,831

 
$
978

 
$
6,490

 
$
16,299

Gross Profit
4,308

 
456

 
2,902

 
7,666

Net Loss before Taxes
(2,614
)
 
(97
)
 
(574
)
 
(3,285
)
Income Tax Benefit
—

 
—

 
(26
)
 
(26
)
Net Loss
$
(2,614
)
 
$
(97
)
 
$
(548
)
 
$
(3,259
)
Depreciation/Amortization
$
847

 
$
68

 
$
130

 
$
1,045

Restructure
$
—

 
$
—

 
$
—

 
$
—

Interest Expense, net
$
(462
)
 
$
(11
)
 
$
(31
)
 
$
(504
)
 
 
 
 
 
 
 
 
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas
Net sales for the three and six months ended June 30, 2012 and 2011 by country were as follows:
 
 
Dollars in Thousands
 
Dollars in Thousands
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2012
 
2011
 
2012
 
2011
United States
$
6,847

 
$
5,669

 
$
11,571

 
$
10,705

Italy
907

 
785

 
1,706

 
1,611

United Kingdom
232

 
233

 
567

 
491

All Other Countries
1,107

 
980

 
2,455

 
2,341

Total
$
9,093

 
$
7,667

 
$
16,299

 
$
15,148